Cargando…
Saffron: A potential drug-supplement for severe acute respiratory syndrome coronavirus (COVID) management
Severe acute respiratory syndrome coronavirus 2, SARS-CoV-2 (COVID-19), came as a significant health care challenge for humans in 2019–20. Based on recent laboratory and epidemiological studies, a growing list of mutations in the virus has the potential to enhance its transmission or help it evade t...
Autores principales: | Husaini, Amjad M., Jan, Khan Nadiya, Wani, Gowher A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118646/ https://www.ncbi.nlm.nih.gov/pubmed/34007917 http://dx.doi.org/10.1016/j.heliyon.2021.e07068 |
Ejemplares similares
-
The menace of saffron adulteration: Low-cost rapid identification of fake look-alike saffron using Foldscope and machine learning technology
por: Husaini, Amjad M., et al.
Publicado: (2022) -
Understanding saffron biology using omics- and bioinformatics tools: stepping towards a better Crocus phenome
por: Husaini, Amjad M., et al.
Publicado: (2022) -
Respiratory management in severe acute respiratory syndrome coronavirus 2 infection
por: Price, Susanna, et al.
Publicado: (2020) -
Predicting the recombination potential of severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome coronavirus
por: Banerjee, Arinjay, et al.
Publicado: (2020) -
The neuroinvasive potential of severe acute respiratory syndrome coronavirus 2
por: Sun, Tong, et al.
Publicado: (2020)